{"id":3618,"date":"2026-07-27T18:49:36","date_gmt":"2026-07-27T16:49:36","guid":{"rendered":"https:\/\/bio-me.bio\/?p=3618"},"modified":"2026-07-27T18:49:37","modified_gmt":"2026-07-27T16:49:37","slug":"personalized-medicine-how-treatment-based-on-your-genes-is-changing-healthcare","status":"publish","type":"post","link":"https:\/\/bio-me.bio\/?p=3618","title":{"rendered":"Personalized Medicine: How Treatment Based on Your Genes Is Changing Healthcare"},"content":{"rendered":"\n<p>Traditional medicine often begins with a standard treatment that works for many patients. Doctors then adjust the medication, dosage, or strategy according to the person\u2019s response.<\/p>\n\n\n\n<p>Personalized medicine aims to make that process more precise from the beginning. It uses information about a patient\u2019s genes, medical history, lifestyle, environment, laboratory results, and sometimes the molecular characteristics of a disease.<\/p>\n\n\n\n<p>The goal is not to create a completely unique medicine for every individual. <strong>The goal is to identify which prevention strategy, diagnostic test, or treatment is most likely to benefit a particular patient.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What Is Personalized Medicine?<\/h3>\n\n\n\n<p>Personalized medicine is closely related to the terms <strong>precision medicine<\/strong>, <strong>individualized medicine<\/strong>, and <strong>genomic medicine<\/strong>.<\/p>\n\n\n\n<p>The National Human Genome Research Institute describes personalized medicine as the use of an individual\u2019s genetic profile to guide decisions about preventing, diagnosing, and treating disease. Precision medicine usually has a broader meaning because it can also include electronic health records, lifestyle, environmental exposure, proteins, and other biological data.<\/p>\n\n\n\n<p>A personalized medical decision might involve:<\/p>\n\n\n\n<ul>\n<li>Choosing a cancer drug based on a tumor mutation<\/li>\n\n\n\n<li>Adjusting a medication dose according to inherited variants<\/li>\n\n\n\n<li>Increasing screening for someone with hereditary disease risk<\/li>\n\n\n\n<li>Avoiding a treatment likely to cause a serious adverse reaction<\/li>\n\n\n\n<li>Classifying a disease by its molecular features rather than symptoms alone<\/li>\n<\/ul>\n\n\n\n<p><strong>Genes can inform treatment, but they rarely provide the entire answer.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">How Genetic Information Can Guide Treatment<\/h3>\n\n\n\n<p>Genes contain instructions that influence how the body develops and functions. Small differences in DNA can affect disease risk, drug metabolism, immune responses, and the biological pathways involved in illness.<\/p>\n\n\n\n<p>A genetic test may examine one variant, a group of genes, the protein-coding exome, or most of the genome.<\/p>\n\n\n\n<p>The result can sometimes reveal why a patient developed a condition or why a particular treatment may work better than another. Genomic medicine is already influencing oncology, pharmacology, rare-disease diagnosis, and infectious-disease care.<\/p>\n\n\n\n<p>However, most common diseases are not caused by one gene. Diabetes, cardiovascular disease, asthma, and many psychiatric conditions result from complex interactions among numerous variants, behavior, age, environment, and chance.<\/p>\n\n\n\n<p>Personalized medicine therefore combines genetic findings with ordinary clinical evidence rather than replacing it.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Pharmacogenomics: Choosing Medicines More Precisely<\/h3>\n\n\n\n<p><strong>Pharmacogenomics<\/strong> studies how genetic variation affects medication response.<\/p>\n\n\n\n<p>Some people break down a drug rapidly, while others process it slowly. The same standard dose may therefore be ineffective for one patient but produce excessive drug levels or adverse effects in another.<\/p>\n\n\n\n<p>Pharmacogenomic information may help a healthcare professional:<\/p>\n\n\n\n<ul>\n<li>Select one medication instead of another<\/li>\n\n\n\n<li>Choose a more appropriate starting dose<\/li>\n\n\n\n<li>Estimate the likelihood of benefit<\/li>\n\n\n\n<li>Reduce the risk of toxicity<\/li>\n\n\n\n<li>Decide whether closer monitoring is necessary<\/li>\n<\/ul>\n\n\n\n<p>NHGRI defines pharmacogenomics as the use of genomic information to help choose medications and dosages predicted to work best for an individual patient.<\/p>\n\n\n\n<p>The FDA maintains tables of pharmacogenetic associations and biomarkers mentioned in drug labeling. These include inherited variants, tumor mutations, gene-expression differences, chromosomal abnormalities, and certain protein biomarkers.<\/p>\n\n\n\n<p>Pharmacogenomic testing does not guarantee that a drug will work. Kidney function, liver function, age, other medications, diet, adherence, and the underlying disease remain important.<\/p>\n\n\n\n<p><strong>Genetics can reduce trial and error, but it does not remove clinical judgment.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Personalized Cancer Treatment<\/h3>\n\n\n\n<p>Cancer is one of the clearest examples of precision medicine.<\/p>\n\n\n\n<p>Two tumors arising in the same organ may contain different molecular changes and respond very differently to treatment. Doctors can analyze a tumor for mutations, proteins, or other biomarkers that influence its growth.<\/p>\n\n\n\n<p>Biomarker testing may help determine whether a patient is likely to benefit from:<\/p>\n\n\n\n<ul>\n<li>A targeted therapy<\/li>\n\n\n\n<li>Immunotherapy<\/li>\n\n\n\n<li>A particular chemotherapy<\/li>\n\n\n\n<li>A clinical trial<\/li>\n\n\n\n<li>More intensive monitoring<\/li>\n<\/ul>\n\n\n\n<p>The National Cancer Institute explains that precision oncology uses information about a tumor to improve diagnosis, treatment selection, evaluation of response, and prognosis.<\/p>\n\n\n\n<p>Some treatments block a specific abnormal protein or molecular pathway. When the relevant biomarker is absent, the same medication may provide little benefit.<\/p>\n\n\n\n<p>Tumor testing is different from inherited genetic testing. <strong>Tumor sequencing examines mutations acquired by cancer cells, while germline testing looks for variants present throughout the body and potentially shared with relatives.<\/strong><\/p>\n\n\n\n<p>Sometimes tumor analysis suggests that an inherited variant may also be present, leading to additional testing and genetic counseling.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Rare and Undiagnosed Diseases<\/h3>\n\n\n\n<p>Personalized genomic medicine can be especially valuable for patients with unexplained symptoms or suspected rare disorders.<\/p>\n\n\n\n<p>A rare genetic disease may affect only a small number of people, making it difficult for an individual doctor to recognize. Exome or genome sequencing can search many genes simultaneously and may identify a molecular diagnosis after years of inconclusive testing.<\/p>\n\n\n\n<p>A diagnosis can:<\/p>\n\n\n\n<ul>\n<li>End a long diagnostic search<\/li>\n\n\n\n<li>Clarify expected complications<\/li>\n\n\n\n<li>Guide surveillance<\/li>\n\n\n\n<li>Identify an available therapy<\/li>\n\n\n\n<li>Prevent unnecessary procedures<\/li>\n\n\n\n<li>Reveal risks for relatives<\/li>\n\n\n\n<li>Support reproductive planning<\/li>\n<\/ul>\n\n\n\n<p>However, sequencing does not always provide an answer. It may find no relevant variant or identify a <strong>variant of uncertain significance<\/strong> whose medical meaning remains unclear.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Disease Prevention Based on Genetic Risk<\/h3>\n\n\n\n<p>Personalized medicine is not limited to treating existing illness.<\/p>\n\n\n\n<p>Certain inherited variants substantially increase the risk of cancers, heart rhythm disorders, abnormal cholesterol levels, or other diseases. When such a variant is identified, doctors may recommend earlier screening, more frequent monitoring, preventive medication, or selected risk-reducing procedures.<\/p>\n\n\n\n<p>The value of this information depends on whether an effective action exists.<\/p>\n\n\n\n<p>A genetic result is most useful when it leads to a clear step, such as:<\/p>\n\n\n\n<ul>\n<li>Earlier colonoscopy<\/li>\n\n\n\n<li>Additional breast imaging<\/li>\n\n\n\n<li>Cardiac monitoring<\/li>\n\n\n\n<li>Testing close relatives<\/li>\n\n\n\n<li>Avoiding a specific medication<\/li>\n\n\n\n<li>Treating dangerously high cholesterol sooner<\/li>\n<\/ul>\n\n\n\n<p>For many low-impact variants, the result changes risk only slightly and may not alter medical care.<\/p>\n\n\n\n<p><strong>A higher genetic risk is not the same as a diagnosis, and a lower genetic risk is not a guarantee of protection.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Why Personalized Medicine Is More Than DNA<\/h3>\n\n\n\n<p>The phrase \u201ctreatment based on your genes\u201d is useful, but incomplete.<\/p>\n\n\n\n<p>Precision medicine may incorporate:<\/p>\n\n\n\n<ul>\n<li>Age and biological sex<\/li>\n\n\n\n<li>Symptoms and medical history<\/li>\n\n\n\n<li>Family history<\/li>\n\n\n\n<li>Lifestyle<\/li>\n\n\n\n<li>Environmental exposure<\/li>\n\n\n\n<li>Imaging<\/li>\n\n\n\n<li>Laboratory tests<\/li>\n\n\n\n<li>Proteins and metabolites<\/li>\n\n\n\n<li>Microorganisms living in and on the body<\/li>\n\n\n\n<li>Electronic health-record data<\/li>\n<\/ul>\n\n\n\n<p>The NCI defines precision medicine as care that uses information about genes, proteins, environment, and lifestyle to prevent, diagnose, or treat disease.<\/p>\n\n\n\n<p>A person\u2019s preferences also matter. Two medically reasonable options may differ in side effects, cost, convenience, fertility implications, or effects on daily life.<\/p>\n\n\n\n<p>Personalized care is therefore not only molecular. It should also reflect what matters to the patient.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">The Limits of Gene-Based Treatment<\/h3>\n\n\n\n<p>Personalized medicine is powerful, but it is not equally developed for every condition.<\/p>\n\n\n\n<p>A test may identify a biological difference without revealing an effective treatment. Some associations are supported by strong clinical evidence, while others come from early research or small studies.<\/p>\n\n\n\n<p>Additional limitations include:<\/p>\n\n\n\n<ul>\n<li>Uncertain genetic findings<\/li>\n\n\n\n<li>Incomplete scientific knowledge<\/li>\n\n\n\n<li>Differences among laboratories<\/li>\n\n\n\n<li>Limited access to specialists<\/li>\n\n\n\n<li>High testing or treatment costs<\/li>\n\n\n\n<li>Underrepresentation of some populations in genomic databases<\/li>\n\n\n\n<li>Difficulty integrating results into ordinary healthcare<\/li>\n\n\n\n<li>The possibility of unexpected family information<\/li>\n<\/ul>\n\n\n\n<p>A test can be technically accurate but clinically unhelpful when the result does not change prevention or treatment.<\/p>\n\n\n\n<p>This principle is called <strong>clinical utility<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Privacy and Genetic Discrimination<\/h3>\n\n\n\n<p>Genetic information is sensitive because it can identify an individual and reveal information about biological relatives.<\/p>\n\n\n\n<p>Patients should understand:<\/p>\n\n\n\n<ul>\n<li>Who can access the result<\/li>\n\n\n\n<li>Where the data will be stored<\/li>\n\n\n\n<li>Whether the sample may be used for research<\/li>\n\n\n\n<li>Whether information may be shared with commercial partners<\/li>\n\n\n\n<li>How long the laboratory retains the data<\/li>\n\n\n\n<li>Whether deletion can be requested<\/li>\n<\/ul>\n\n\n\n<p>Legal protections differ among countries and may not cover every form of insurance, employment, research, or commercial testing.<\/p>\n\n\n\n<p>Unexpected discoveries can also affect families. A test may reveal inherited disease risk, previously unknown relatives, or biological relationships that differ from what a person believed.<\/p>\n\n\n\n<p>Genetic counseling can help patients consider these possibilities before testing.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Expert Perspective<\/h3>\n\n\n\n<p>The National Human Genome Research Institute describes genomic medicine as the use of a person\u2019s genomic information in clinical care to support diagnosis, predict outcomes, and guide treatment.<\/p>\n\n\n\n<p>The FDA takes a similarly practical view. Its pharmacogenetic guidance states that a patient\u2019s genotype may help determine treatment strategy, dosage, expected benefit, or the likelihood of toxicity\u2014but only alongside other clinical information.<\/p>\n\n\n\n<p>These perspectives highlight the central rule of personalized medicine: <strong>genetic information becomes medically valuable when it improves a real decision rather than merely producing more data.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Who May Benefit Most?<\/h3>\n\n\n\n<p>Personalized or genomic evaluation may be particularly useful for people who have:<\/p>\n\n\n\n<ul>\n<li>A suspected inherited disorder<\/li>\n\n\n\n<li>Cancer that may respond to targeted treatment<\/li>\n\n\n\n<li>An unusual or difficult-to-diagnose condition<\/li>\n\n\n\n<li>Serious reactions to certain medications<\/li>\n\n\n\n<li>A strong family history of early disease<\/li>\n\n\n\n<li>A known pathogenic variant in the family<\/li>\n\n\n\n<li>A medication with established pharmacogenomic guidance<\/li>\n\n\n\n<li>Multiple unsuccessful treatment attempts<\/li>\n<\/ul>\n\n\n\n<p>Broad genetic testing is not necessary for every patient.<\/p>\n\n\n\n<p>Before testing, it is reasonable to ask what question the test is intended to answer, what actions may follow, whether the result requires confirmation, and who will interpret it.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Interesting Facts<\/h3>\n\n\n\n<ul>\n<li>Humans have roughly the same set of genes, but millions of DNA differences contribute to individual variation.<\/li>\n\n\n\n<li>A tumor\u2019s genetic profile can differ substantially from the inherited DNA in the rest of the body.<\/li>\n\n\n\n<li>Pharmacogenomic information appears in the labeling of many medicines.<\/li>\n\n\n\n<li>Some targeted cancer therapies are selected according to a molecular alteration rather than only the organ where the cancer began.<\/li>\n\n\n\n<li>Genetic variants can affect both medication effectiveness and the likelihood of adverse reactions.<\/li>\n\n\n\n<li>Exome sequencing focuses mainly on protein-coding regions, which represent only a small portion of the genome.<\/li>\n\n\n\n<li>A genetic diagnosis may benefit relatives who have never shown symptoms.<\/li>\n\n\n\n<li>Personalized medicine often uses environmental and lifestyle data as well as genetics.<\/li>\n\n\n\n<li>The same pathogenic variant may produce different symptoms in different people.<\/li>\n\n\n\n<li>A large genetic panel is not automatically more useful than a carefully selected test.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Glossary<\/h3>\n\n\n\n<ul>\n<li><strong>Personalized Medicine<\/strong> \u2014 Medical care adapted to characteristics of an individual patient, including genetics, health history, environment, and preferences.<\/li>\n\n\n\n<li><strong>Precision Medicine<\/strong> \u2014 An approach that uses biological, clinical, environmental, and lifestyle data to guide prevention, diagnosis, or treatment.<\/li>\n\n\n\n<li><strong>Genomic Medicine<\/strong> \u2014 The use of genomic information as part of clinical care.<\/li>\n\n\n\n<li><strong>Genome<\/strong> \u2014 The complete set of an individual\u2019s genetic material.<\/li>\n\n\n\n<li><strong>Genetic Variant<\/strong> \u2014 A difference in DNA sequence between individuals or cells.<\/li>\n\n\n\n<li><strong>Pathogenic Variant<\/strong> \u2014 A genetic change supported by evidence as causing or increasing the risk of disease.<\/li>\n\n\n\n<li><strong>Pharmacogenomics<\/strong> \u2014 The study of how genetic variation influences medication response.<\/li>\n\n\n\n<li><strong>Biomarker<\/strong> \u2014 A measurable biological characteristic used to assess disease, predict response, or guide treatment.<\/li>\n\n\n\n<li><strong>Targeted Therapy<\/strong> \u2014 Treatment designed to act on a specific molecule or pathway involved in disease.<\/li>\n\n\n\n<li><strong>Tumor Sequencing<\/strong> \u2014 Analysis of genetic changes found within cancer cells.<\/li>\n\n\n\n<li><strong>Germline Variant<\/strong> \u2014 An inherited or reproductive-cell genetic variant generally present throughout the body.<\/li>\n\n\n\n<li><strong>Somatic Variant<\/strong> \u2014 A genetic change acquired by certain cells during a person\u2019s lifetime.<\/li>\n\n\n\n<li><strong>Exome Sequencing<\/strong> \u2014 Analysis of most protein-coding regions of the genome.<\/li>\n\n\n\n<li><strong>Variant of Uncertain Significance<\/strong> \u2014 A genetic change whose medical effect is not yet understood.<\/li>\n\n\n\n<li><strong>Clinical Utility<\/strong> \u2014 The likelihood that a test result will improve a practical medical decision.<\/li>\n\n\n\n<li><strong>Genetic Counseling<\/strong> \u2014 Professional guidance that helps patients understand genetic risks, tests, and possible results.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Traditional medicine often begins with a standard treatment that works for many patients. Doctors then adjust the medication, dosage, or strategy according to the person\u2019s response. Personalized medicine aims to&hellip;<\/p>\n","protected":false},"author":2,"featured_media":3619,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[58,74,67],"tags":[],"_links":{"self":[{"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/posts\/3618"}],"collection":[{"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bio-me.bio\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3618"}],"version-history":[{"count":1,"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/posts\/3618\/revisions"}],"predecessor-version":[{"id":3620,"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/posts\/3618\/revisions\/3620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bio-me.bio\/index.php?rest_route=\/wp\/v2\/media\/3619"}],"wp:attachment":[{"href":"https:\/\/bio-me.bio\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bio-me.bio\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bio-me.bio\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}